Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival.
about
Prostate cancer relevant antigens and enzymes for targeted drug deliveryPrognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis.Prognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta-analysis.Integrated network model provides new insights into castration-resistant prostate cancerCombined upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 predicts unfavorable prognosis in human nasopharyngeal carcinoma.Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?The Anticancer Role of Capsaicin in Experimentallyinduced Lung Carcinogenesis.Resveratrol-zinc combination for prostate cancer management.Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.Identification and validation of the role of matrix metalloproteinase-1 in cervical cancer.Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate.Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.TIMP2 is a Poor Prognostic Factor and Predicts Metastatic Biological Behavior in Gastric Cancer.
P2860
Q27013843-17BFDE60-C2FD-4EA7-99A8-D379DF686660Q33621452-00D10BBC-839B-48E5-8B04-5553EC69995DQ35480244-B84DDA9B-F77A-442F-9BD3-53939D40EA6DQ36316657-5136F2E9-1BB0-402E-A167-4A8A2A1200CCQ37125603-80A18A2C-C18D-4927-9504-F0C34CF5CEABQ38224605-0560EF48-B58A-49C9-B517-A5C0904738F4Q38812074-75950264-FC4D-4C07-A289-E49DA45347D1Q41548112-F5EE44A8-CC37-4891-BBC7-8716DDAF34CAQ42186001-1FAD1145-F86F-43E8-8EC7-AA8ACDA5182EQ42750085-4F35D15B-6B05-438A-A7D9-D6ACBD18CA25Q47327727-1D198B61-8239-4806-BC63-36473B878B2FQ50047865-FCF36E0E-072B-46FF-A2F7-37974B49B7DCQ50059023-A4296A46-ADE8-4964-AFE6-C87DB2CF7E94Q51125940-11BD71CD-B3C1-4167-B761-7E85BDF2A920Q55472607-0279AC77-6F2F-4A09-8B7B-21793B4A690C
P2860
Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Expression of MMP-1, MMP-9 and ...... nce on prognosis and survival.
@en
Expression of MMP-1, MMP-9 and ...... nce on prognosis and survival.
@nl
type
label
Expression of MMP-1, MMP-9 and ...... nce on prognosis and survival.
@en
Expression of MMP-1, MMP-9 and ...... nce on prognosis and survival.
@nl
prefLabel
Expression of MMP-1, MMP-9 and ...... nce on prognosis and survival.
@en
Expression of MMP-1, MMP-9 and ...... nce on prognosis and survival.
@nl
P2093
P2860
P1476
Expression of MMP-1, MMP-9 and ...... ence on prognosis and survival
@en
P2093
Caner Saygin
Didem Uzunaslan
Ferhat Ozden
Haydar Durak
P2860
P2888
P304
P356
10.1007/S00432-013-1453-X
P50
P577
2013-05-25T00:00:00Z